Caffeine Regulates Neuronal Expression of the Dopamine 2 Receptor Gene

Molecular Pharmacology

Volumn 64, Issue 6, 2003, Pages 1463-1473

  Stonehouse, Anthony H ^a   Adachi, Megumi ^a   Walcott, Elisabeth C ^a   Jones, Frederick S ^a  

^a NEUROSCIENCES INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 8 (3 CHLOROSTYRYL)CAFFEINE; ADENOSINE A2 RECEPTOR; CAFFEINE; DOPAMINE 2 RECEPTOR; LUCIFERASE; MESSENGER RNA;

5' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRAIN; CONTROLLED STUDY; CORPUS STRIATUM; EMBRYO; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; MALE; MOUSE; NERVE CONDUCTION; NEUROTRANSMISSION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; REPORTER GENE; SEX DIFFERENCE;

ANIMALS; CAFFEINE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION REGULATION; MALE; MICE; NEURONS; PC12 CELLS; RATS; RECEPTORS, DOPAMINE D2;

EID: 0345735769     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.64.6.1463     Document Type: Article

References (40)

1. Aizman O, Brismar H, Uhlen P, Zettergren E, Levey AI, Forssberg H, Greengard P, and Aperia A (2000) Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons. Nat Neurosci 3:226-230.
2. Arslan G, Kull B, and Fredholm BB (1999) Signaling via A2A adenosine receptor in four PC12 cell clones. Naunyn Schmiedeberg's Arch Pharmacol 359:28-32.
3. Ascherio A, Zhang SM, Hernan MA, Kawachi I, Colditz GA, Speizer FE, and Willett WC (2001) Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Ann Neurol 50:56-63.
4. Carlsson A (1959) The occurrence, distribution and physiological role of catecholamines in the nervous system. Pharmacol Rev 11:490-493.
5. Chen JF, Xu K, Petzer JP, Staal R, Xu YH, Beilstein M, Sonsalla PK, Castagnoli K, Castagnoh N Jr, and Schwarzschild MA (2001) Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease. J Neurosci 21:RC143.
6. Copertino DW, Edelman GM, and Jones FS (1997) Multiple promoter elements differentially regulate the expression of the mouse tenascin gene. Proc Natl Acad Sci USA 94:1846-1851.
7. Diaz-Cabiale Z, Hurd Y, Guidolin D, Finnman UB, Zoli M, Agnati LF, Vanderhaeghen JJ, Fuxe K, and Ferre S (2001) Adenosine A2A agonist CGS 21680 decreases the affinity of dopamine D2 receptors for dopamine in human striatum. Neuroreport 12:1831-1834.
8. D'Souza DN, Harlan RE and Garcia MM (1999) Sexual dimorphism in the response to N-methyl-D-aspartate receptor antagonists and morphine on behavior and c-Fos induction in the rat brain. Neuroscience 93:1539-1547.
9. D'Souza DN, Harlan RE and Garcia MM (2002) Sexually dimorphic effects of morphine and MK-801: sex steroid-dependent and -independent mechanisms. J Appl Physiol 92:493-503.
10. Ferre S, Fredholm BB, Morelli M, Popoli P, and Fuxe K (1997) Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci 20:482-487.
11. Ferre S and Fuxe K (1992) Dopamine denervation leads to an increase in the intramembrane interaction between adenosine A2 and dopamine D2 receptors in the neostriatum. Brain Res 594:124-130.
12. Ferre S, Herrera-Marschitz M, Grabowska-Anden M, Ungerstedt U, Casas M, and Anden NE (1991a) Postsynaptic dopamine/adenosine interaction: I. Adenosine analogues inhibit dopamine D2-mediated behaviour in short-term reserpinized mice. Eur J Pharmacol 192:25-30.
13. Ferre S, von Euler G, Johansson B, Fredholm BB, and Fuxe K (1991b) Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. Proc Natl Acad Sci USA 88:7238-7241.
14. Fredholm BB, Battig K, Holmen J, Nehlig A, and Zvartau EE (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51:83-133.
15. Fuxe K and Ungerstedt U (1974) Action of caffeine and theophyllamine on supersensitive dopamine receptors: considerable enhancement of receptor response to treatment with DOPA and dopamine receptor agonists. Med Biol 52:48-54.
16. Gingrich JA and Caron MG (1993) Recent advances in the molecular biology of dopamine receptors. Annu Rev Neurosci 16:299-321.
17. Greengard P (2001) The neurobiology of dopamine signaling. Biosci Rep 21:247-269.
18. Gross GW (1979) Simultaneous single unit recording in vitro with a photoetched laser deinsulated gold multimicroelectrode surface. IEEE Trans Biomed Eng 26:273-279.
19. Hwang CK, D'Souza UM, Eisch AJ, Yajima S, Lammers CH, Yang Y, Lee SH, Kim YM, Nestler EJ, and Mouradian MM (2001) Dopamine receptor regulating factor, DRRF: a zinc finger transcription factor. Proc Natl Acad Sci USA 98:7558-7563.
20. Ikeda K, Kurokawa M, Aoyama S, and Kuwana Y (2002) Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinson's disease. J Neurochem 80:262-270.
21. Johansson B, Lindstrom K, and Fredholm BB (1994) Differences in the regional and cellular localization of c-fos messenger RNA induced by amphetamine, cocaine and caffeine in the rat. Neuroscience 59:837-849.
22. Koizumi S and Inoue K (1998) Functional coupling of secretion and capacitative calcium entry in PC12 cells. Biochem Biophys Res Commun 244:293-297.
23. 3H]quinpirole binding to D2-like dopamine receptors in rat brain. J Pharmacol Exp Ther 262:929-935.
24. Lewis DA and Lieberman JA (2000) Catching up on schizophrenia: natural history and neurobiology. Neuron 28:325-334.
25. Lindskog M, Svenningsson P, Pozzi L, Kim Y, Fienberg AA, Bibb JA, Fredholm BB, Nairn AC, Greengard P, and Fisone G (2002) Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine. Nature (Lond) 418:774-778.
26. Maltais S, Cote S, Drolet G, and Falardeau P (2000) Cellular colocalization of dopamine D1 mRNA and D2 receptor in rat brain using a D2 dopamine receptor specific polyclonal antibody. Prog Neuropsychopharmacol Biol Psychiatry 24:1127-1149.
27. Mauro VP and Edelman GM (2002) The ribosome filter hypothesis. Proc Natl Acad Sci USA 99:12031-12036.
28. McGeer PL, Itagaki S, Akiyama H, and McGeer EG (1988) Rate of cell death in parkinsonism indicates active neuropathological process. Ann Neurol 24:574-576.
29. Minowa T, Minowa MT, and Mouradian MM (1994) Negative modulator of the rat D2 dopamine receptor gene. J Biol Chem 269:11656-11662.
30. Mistry SK, Keefer EW, Cunningham BA, Edelman GM, and Crossin KL (2002) Cultured rat hippocampal neural progenitors generate spontaneously active neural networks. Proc Natl Acad Sci USA 99:1621-1626.
31. 2L receptor stimulation of the mitogen-activated protein kinase pathway is dependent on trans-activation of the platelet-derived growth factor receptor. Mol Pharmacol 60:92-103.
32. Schiffmann SN and Vanderhaeghen JJ (1993) Adenosine A2 receptors regulate the gene expression of striatopallidal and striatonigral neurons. J Neurosci 13:1080-1087.
33. Schwarzschild MA, Chen JF, and Ascherio A (2002) Caffeinated clues and the promise of adenosine A(2A) antagonists in PD. Neurology 58:1154-1160.
34. Stoof JC and Kebabian JW (1984) Two dopamine receptors: biochemistry, physiology and pharmacology. Life Sci 35:2281-2296.
35. Svenningsson P, Lindskog M, Ledent C, Parmentier M, Greengard P, Fredholm BB and Fisone G (2000) Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2 and adenosine A2A receptors. Proc Natl Acad Sci USA 97:1856-1860.
36. 2+/calmodulin-dependent protein kinase II pathways. J Neurochem 83:784-796.
37. Welsh GI, Hall DA, Warnes A, Strange PG, and Proud CG (1998) Activation of microtubule-associated protein kinase (Erk) and p70 S6 kinase by D2 dopamine receptors. J Neurochem 70:2139-2146.
38. Xu K, Xu YH, Chen JF, and Schwarzschild MA (2002) Caffeine's neuroprotection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity shows no tolerance to chronic caffeine administration in mice. Neurosci Lett 322:13-16.
39. Zhen Meng S, Obonai T, and Takashima S (1998) A developmental study of the dopamine D2R receptors in the human basal ganglia and thalamus. Early Hum Dev 51:23-30.
40. Zhu WH, Conforti L and Millhorn DE (1997) Expression of dopamine D2 receptor in PC-12 cells and regulation of membrane conductances by dopamine. Am J Physiol 273:C1143-C1150.